Intuitive Surgical Inc (ISRG · NASDAQ)

ISRG · MARKET VIEW

Market view · as of Jun 2, 2026

Revenue (TTM)
$10.58B
+23.0% YoY
Gross margin
66.3%
EPS (latest q)
$2.50
vs $2.11 est · beat
52-wk position
0.0%
-30.5% vs 52w high · -9.9% 1mo

Price (last ~year)

Intuitive Surgical, developer of the da Vinci Surgical System, maintains a debt-free balance sheet with $2.04 billion in cash and reported 23.0% year-over-year revenue growth. Despite beating earnings estimates in each of the last four quarters, the stock has declined 17.0% over the past three months and currently trades 30.5% below its 52-week high. The company recently appointed Taylor Patton as its new Chief Commercial and Marketing Officer to lead its commercial strategy.

Valuation

Market cap
$150.39B
P/E
51.53
PEG
2.227
P/B
8.61
P/S
14.21
EV/EBITDA
36.93
Beta
1.509
Analyst target
$567.8

Quality & returns

Gross margin
66.3%
Operating margin
30.9%
Profit margin
28.1%
ROE
17.2%
ROA
10.2%

Price movement

Last
$412.26
1-month
-9.9%
3-month
-17.0%
RSI (14)
46
vs SMA200
-16.7%
52-wk position
0.0% -30.5% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$2.77B$855.3M$821.5M$855.3M
2025-12-31$2.87B$864.3M$794.8M$1.09B
2025-09-30$2.51B$759.7M$704.4M$919.7M
2025-06-30$2.44B$743.4M$658.4M$898.7M

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)